Glycerin Suppositories
Natural health product licensed in Canada
- Licence holder
- Teva Canada Limited
- NPN or DIN-HM
- 02020815
- Status
- Active licence
- Licence date
- 10 July 2008
- Revision date
- 7 April 2022
- Form
- Suppositoire
- Route of administration
- Rectale
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Hydroxyde de sodium, Acide stéarique, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2 years | 1 suppositoire | 1 Tous les jours |
| Enfants | maximum: 2 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Laxative for the rapid relief of occasional constipation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 02020815
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.